Recession shines light on inventory

Reducing inventory is the top action manufacturers have taken in response to the recession, as reported by more than half of respondents to a survey. Findings in the Aberdeen study show that 91 percent of companies indicate that they are reviewing opportunities to improve inventory performance through process change. Some 61 percent say they have made, or have been asked to make, inventory-related technology recommendations within the past six months. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.